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in the absence of a pathologica
diac murmur.6 By definition, it 
possible to identify children who
subclinical RHD using auscul
screening alone, and published
consistently show that ausculta3) · 5 August 2013Objectives:  To evaluate the utility of auscultatory screening for detecting 
echocardiographically confirmed rheumatic heart disease (RHD) in high-risk 
children in the Northern Territory, Australia.
Design:  Cross-sectional screening survey.
Setting:  Twelve rural and remote communities in the NT between September 
2008 and June 2010.
Participants:  1015 predominantly Indigenous schoolchildren aged 5–15 years.
Intervention:  All children underwent transthoracic echocardiography, using a 
portable cardiovascular ultrasound machine, and cardiac auscultation by a 
doctor and a nurse. Sonographers and auscultators were blinded to each others’ 
findings and the clinical history of the children. Echocardiograms were reported 
offsite, using a standardised protocol, by cardiologists who were also blinded to 
the clinical findings.
Main outcome measures:  Presence of a cardiac murmur as identified by nurses 
(any murmur) and doctors (any murmur, and “suspicious” or “pathological” 
murmurs), compared with echocardiogram findings. RHD was defined 
according to the 2012 World Heart Federation criteria for echocardiographic 
diagnosis of RHD.
Results:  Of the 1015 children screened, 34 (3.3%) had abnormalities identified 
on their echocardiogram; 24 met echocardiographic criteria for definite or 
borderline RHD, and 10 had isolated congenital anomalies. Detection of any 
murmur by a nurse had a sensitivity of 47.1%, specificity of 74.8% and positive 
predictive value (PPV) of 6.1%. Doctor identification of any murmur had 38.2% 
sensitivity, 75.1% specificity and 5.1% PPV, and the corresponding values for 
doctor detection of suspicious or pathological murmurs were 20.6%, 92.2% and 
8.3%. For all auscultation approaches, negative predictive value was more than 
97%, but the majority of participants with cardiac abnormalities were not 
identified. The results were no different when only definite RHD and congenital 
abnormalities were considered as true cases.
Conclusions:  Sensitivity and positive predictive value of cardiac auscultation 
compared with echocardiography is poor, regardless of the expertise of the 
auscultator. Although negative predictive value is high, most cases of heart 
disease were missed by auscultation, suggesting that cardiac auscultation should 
no longer be used to screen for RHD in high-risk schoolchildren in Australia.
Abstracth
(R
of R euma t i c  h ear t  d i s eas eHD), the long-term sequelacute rheumatic fever, is a
leading cause of heart disease in chil-
dren in low- and middle-income
countries.1 Poverty and overcrowding
are known risk factors for RHD,2 and
with improvements in socioeconomic
conditions, the disease has essentially
disappeared from industrialised coun-
tries, with the exceptions of the Indi-
genous populations of Australia and
New Zealand.3 Indigenous Austral-
ians continue to experience among
the highest rates in the world, with an
acute rheumatic fever incidence of up
to 380 per 100 000 children aged 5–14
years, and an estimated RHD pre-
valence of 8.5 per 1000 children in this
age group.4 A recent government
report shows that young Indigenous
Australians (< 35 years) in the North-
ern Territory have a 122-fold greater
prevalence of RHD than non-Indi-
genous Australians.5
In populations with high pre-
valence, RHD satisfies many of the
criteria for a disease to be deemed
suitable for screening,6 and RHD has
long been a target of public health
screening internationally. Cardiac
auscultation was the traditional
approach,7 but with the evolution of
portable echocardiography there has
been increasing interest in echocardi-
ographic screening for RHD.8-15 In the
echocardiographic era, a new category
of RHD has been recognised: “sub-
clinical RHD”, defined as structural or
functional changes consistent with
RHD evident on an echocardiogram
l car-
is not
 have
tatory
 data
tion is
considerably less sensitive than
echocardiography, missing up to 90%
of cases of RHD in some studies.8
Also of concern is the high false-
positive rate associated with ausculta-
tion, resulting in many children
undergoing further unnecessary diag-
nostic evaluation.9,16
Auscultatory screening for RHD
commenced in the NT in 1997 and is
still used today. Cardiac auscultation
is performed by primary care doctors
on schoolchildren aged 10 and 15
years who live in remote Indigenous
communities; those with a cardiac
murmur are referred for echocardio-
graphy.17 The NT is the only jurisdic-
tion in Australia with a formal RHD
screening program.
As part of a large echocardiographic
screening study undertaken in north-
ern Australia, we performed cardiac
auscultation on a subset of schoolchil-
dren in remote Indigenous communi-
ties in the NT and compared clinical
findings with echocardiographic find-
ings. We aimed to establish whether
cardiac auscultation is an appropriate
tool for RHD screening to identify
children who should be referred for
echocardiography.
Methods
Setting and participants
Our study was conducted in 12 rural
and remote communities in Central
Australia and the Top End of the NT
between September 2008 and June
2010. Children aged 5–15 years, iden-
tified by school enrolment records,
were eligible to participate. These
children were a subset of a larger
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◆group of children, from 17 communi-
ties in Northern Australia, who had
echocardiography performed for a
larger study. Nurse and doctor auscul-
tators were present during visits to the
12 communities, and all the children
in these communities who were par-
ticipating in the larger study were
eligible to participate in the ausculta-
tion component.
Written informed consent was
obtained from parents and guardians,
and written assent was obtained from
children aged  13 years before they
took part. Ethics approval was
obtained from the Human Research
Ethics Committee of the Northern
Territory Department of Health and
Community Services, and the Central
Australian Human Research Ethics
Committee.
Echocardiography
All children had a screening echocar-
diogram performed by an experienced
cardiac sonographer using a Vivid e
(GE Healthcare) portable cardiovas-
cular ultrasound machine. Sono-
graphers were bl inded to  the
auscultators’ findings and to the clini-
cal history of the children. Screening
echocardiograms were performed
according to an abbreviated protocol,
previously used in Tonga and Fiji,9,16
that focused on the mitral and aortic
valves, but would also enable detec-
tion of significant congenital lesions.
If a potential abnormality was
detected, a complete echocardiogram
was performed.
Echocardiograms were recorded to
DVD and reported offsite by a pool of
14 cardiologists who were blinded to
the clinical findings. Detailed data
about the mitral and aortic valves were
entered into an electronic database.
Children were classified as having
definite or borderline RHD according
to the 2012 World Heart Federation
(WHF) criteria for the echocardio-
graphic diagnosis of RHD.18 This was
done by extracting each individual
echocardiographic feature, as objec-
tively measured and recorded by
reporting cardiologists, and combin-
ing features to determine whether
WHF definitions were met. Children
were also classified as having patho-
logical mitral regurgitation or patho-
logical aortic regurgitation according
to these criteria.
Cardiac auscultation
Children underwent auscultation per-
formed by a nurse and a doctor who
were blinded to the sonographers’
findings, each others’ findings and to
the clinical history of the children.
Auscultation was performed by
nurses with varying levels of experi-
ence and doctors of different special-
ties (including general practitioners,
paediatricians and cardiologists). It
was completed with children supine
and sitting, in a quiet room where
possible. The diaphragm and bell of
the stethoscope were used at the apex
and axilla, lower left sternal edge,
upper left sternal edge and upper
right sternal edge. The nurses and
doctors who performed auscultation
were asked to comment on the pres-
ence or absence of a murmur. The
doctors were further asked to specify
whether a murmur was “innocent”,
“suspicious” or “pathological”. Suspi-
cious and pathological murmurs were
classified as “significant” murmurs.
This enabled assessment of three
screening approaches: one-stage aus-
cultation by a nurse to detect any
murmur; one-stage auscultation by a
doctor to detect any significant mur-
mur; and two-stage auscultation, with
the first stage to detect any murmur
by a nurse and the second stage to
detect which of these was significant
by a doctor.
Analysis
Statistical analysis was performed
using Stata statistical package version
12.1 (StataCorp). Sensitivity, specifi-
city, positive predictive value (PPV)
and negative predictive value (NPV)
were calculated for each screening
approach.
Results
A total of 1986 NT children had a
screening echocardiogram as part of
the larger study, of whom 1015 had
auscultation performed by a doctor
1 Comparison of auscultation findings with echocardiographic findings for 1015 children from rural and remote parts of the Northern
2008–2010
Auscultation approach
No. of children 
with abnormalities* 
(n= 34)
No. of children 
without abnormalities 
(n= 981)
Sensitivity 
(95% CI)
Specificity 
(95% CI)
PPV 
(95% CI)
NPV 
(95% C
One stage, by nurse
Any murmur 16 247 47.1% 
(29.8%–64.9%)
74.8% 
(72.0%–77.5%)
6.1% 
(3.5%–9.7%)
97.6%
(96.2%–98No murmur 18 734
One stage, by doctor
Any murmur 13‡ 244 38.2% 
(22.2%–56.4%)
75.1% 
(72.3%–77.8%)
5.1% 
(2.7%–8.5%)
97.2%
(95.8%–98No murmur 21§ 737
One stage, by doctor
Significant murmur¶ 7 77 20.6% 
(8.7%–37.9%)
92.2% 
(90.3%–93.8%)
8.3% 
(3.4%–16.4%)
97.1% 
(95.8%–98No significant murmur 27 904
Two stage**
Significant murmur 6 51 17.6% 
(6.8%–34.5%)
94.8% 
(93.2%–96.1%)
10.5% 
(4.0%–21.5%)
97.1% 
(95.8%–98No significant murmur 28 930
PPV = positive predictive value. NPV = negative predictive value. AUC = area under the receiver operating characteristic curve. * Definite or borderline rheumatic h
congenital abnormalities detected on echocardiogram; there was no difference in the findings when only definite rheumatic heart disease and congenital abnor
considered true cases (data not shown). † AUC is a measure of overall test accuracy; 0.5 indicates zero discrimination, and values approaching 1.0 indicate high 
speciﬁcity. ‡ Includes 8 children with rheumatic heart disease (5 deﬁnite, 3 borderline) and 5 with congenital heart disease. § Includes 16 children with rheumatic
definite, 6 borderline) and 5 with congenital heart disease. ¶ Includes 20 pathological and 64 suspicious cardiac murmurs. ** By a nurse to identify any murmur,
identify significant murmur.197MJA 199 (3) · 5 August 2013
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echocardiographic definand a nurse; 960 (94.6%) were Indi-
genous and 498 were girls (49.1%).
The mean age was 9.3 years (SD, 2.5
years), and the median body mass
index was 15.6 kg/m2 (interquartile
range, 14.4–17.8 kg/m2). Children
who had an echocardiogram but did
not undergo auscultation were
slightly older (mean age, 9.7 years),
but were otherwise comparable based
on sex and body mass index.
Echocardiographic findings
Thirty-four children (3.3%) had
abnormalities identified on their
echocardiogram. Fifteen (1.5%) of
them had definite RHD, 9 (0.9%) had
borderline RHD (including two who
also had small atrial septal defects),
and 10 (1.0%) had isolated congenital
anomalies: ventricular septal defect
(two), atrial septal defect (one), mitral
valve prolapse (two), patent ductus
arteriosus (two), dilated aortic root
(two) and complex congenital heart
disease (one). Of the 24 children with
RHD, 14 had pathological mitral
regurgitation, six had pathological
aortic regurgitation, and one child had
both.
Clinical findings
One-stage auscultation
A cardiac murmur (significant or not)
was heard by nurses in 263 children
(25.9%), by doctors in 257 children
(25.3%), and by a doctor and a nurse in
137 children (13.5%). Compared with
echocardiogram, one-stage ausculta-
tion to detect any murmur by a doctor
or a nurse had a sensitivity of less than
50%, a specificity of about 75%, and a
positive predictive value (PPV) of less
than 10% (Box 1). Asking doctors to
decide which murmurs were patholo-
gical or suspicious increased the specif-
icity from 75.1% to 92.2%, but further
dropped the sensitivity to 20.6%. The
breakdown of medical specialists and
their auscultation findings are pre-
sented in Box 2.
Two-stage auscultation
Only 52% (137/263) of the murmurs
heard by nurses were also heard by
doctors. Of these, 57 were considered
pathological or suspicious. Using
two-stage auscultation, 28 children
with abnormalities were missed (sen-
sitivity, 17.6%), and six children with
abnormalities were correctly identi-
fied (PPV, 10.5%). This approach had
a specificity of 94.8%.
Discussion
Our study confirms that cardiac aus-
cultation has poor sensitivity, despite
moderately high specificity, for
detecting RHD and other cardiac
abnormalities evident on echocardio-
grams, regardless of the experience of
the examiner. More than 50% of chil-
dren with abnormal echocardiogra-
phy results did not have a murmur
detected, and more than 90% of mur-
murs heard were false positives. The
observed high NPVs and low PPVs
are expected in a low-prevalence dis-
ease such as RHD, and are consistent
with the results of previous studies
(Box 3). Our findings highlight the
paramount importance of sensitivity
in determining the utility of ausculta-
tion as a screening test for RHD.
The current approach to screening
for RHD in the NT is one-stage doctor
auscultation by a GP, with referral of
any child with a murmur for an
echocardiogram.17 Program reports
suggest that cardiac murmurs are
e-stage doctor auscultation findings with echocardiographic findings, by specialty of doctors who performed auscultation, for 
l and remote parts of the Northern Territory, 2008–2010
No. of children who 
underwent auscultation
No. of children with 
abnormalities*
No. (%) of children with 
any murmur
No. (%) of children with 
significant murmur Sensitivity† Specificity†
157 8 33 (21.0%) 14 (8.9%) 12.5% 91.3%
637 17 159 (25.0%) 48 (7.5%) 17.7% 92.7%
106 4 37 (34.9%) 2 (1.9%) 0 98.0%
45 2 14 (31.1%) 7 (15.6%) 100.0% 88.4%
er 70 3 14 (20.0%) 13 (18.6%) 33.3% 82.1%
1015 34 257 (25.3%) 84 (8.3%) 20.6% 92.2%
heumatic heart disease and congenital abnormalities detected on echocardiogram. † Comparison of doctor identification of significant cardiac murmur with 
d on echocardiogram. ◆
scultation findings with echocardiographic findings in three large rheumatic heart disease screening studies
Country (auscultator)
Mozambique 
(physician)8
Tonga
(medical student)9
Tonga 
(paediatrician)9
Fiji 
(paediatrician)16
derwent auscultation 2170 980 980 3462
derwent echocardiography 2170 980 980 331
normalities detected on echocardiogram 71 140 140 41
ith any murmur 456 (21%) 964 (98%) 779 (79%) 889 (26%)
ith significant murmur 91 (4%) NA 358 (37%) 359 (10%)
14% 96% 46% NA
96% 1% 65% NA
ue* 11% 14% 18% 14%
lue* 97% 69% 88% NA
omparison of significant murmurs (where reported) with any abnormality (rheumatic heart disease and congenital heart disease) detected on echocardiogram; 
itions of rheumatic heart disease varied slightly between studies. ◆3) · 5 August 2013
Researchheard in about 10% of  those
screened,19 but few data regarding
follow-up and clinical outcomes for
these children are available. In a
detailed report on RHD screening in
Central Australia during 2009, 67 of
1095 children who were screened
(6.1%) had a murmur and were
referred for echocardiography. One
year later, only 38 of them had had
their echocardiogram, of whom four
had abnormalities (two RHD, two
non-RHD abnormalities).19 This prev-
alence of RHD (2 per 1000 children) is
considerably lower than expected in
the Central Australian population and
suggests that some disease went
undetected. In addition, the fact that
nearly half of referred children had
not had their echocardiogram 12
months later also highlights difficul-
ties with the current approach.
According to the current NT screen-
ing model (one-stage doctor ausculta-
tion), 257 children in our study would
have been referred for echocardio-
gram, with only 13 of them having
abnormalities (eight with RHD, five
with congenital heart disease). A high
false-positive rate has important impli-
cations for screening programs, to both
the individual and the health system.
In the NT, limited paediatric cardiology
services exist, and waiting times for
echocardiography can be long. Such
high false-positive rates would result in
a substantial increase in referral of chil-
dren to tertiary services for further
evaluation, and would risk overbur-
dening already-stretched paediatric
cardiology services with children who
do not have heart disease.
Of greatest concern, however, is that
using the current approach to RHD
screening, 16 of 24 children with RHD
(10 with definite RHD, six with border-
line RHD) would have been missed.
While there is uncertainty about the
significance of the borderline RHD cat-
egory, the WHF recommends that all
children meeting echocardiographic
criteria for definite RHD be started on
secondary prophylaxis.18 In our study,
the 10 children who met these criteria
but did not have murmur detected by
one-stage doctor auscultation would
not have had further evaluation and
would not have commenced secondary
antibiotic prophylaxis, leaving them at
high risk of acute rheumatic fever
recurrences and further valve damage.
The prognosis of RHD is best if sec-
ondary prophylaxis with long-acting
intramuscular penicillin is commenced
when the disease is mild; continuous
adherence to treatment with penicillin
can result in valve damage being
halted or reversed.20-22 It is therefore
imperative that the test used to screen
for RHD is highly sensitive, so that
children with the earliest stage of dis-
ease, who stand to gain the most from
the only currently available preventive
treatment, are identified.
It is widely accepted that echocardio-
graphy is more sensitive than ausculta-
tion. While there has been much
discussion about echocardiographic
definitions of RHD, including concerns
about specificity, it is hoped that the
publication of the WHF diagnostic cri-
teria will minimise false-positive
results. Whether echocardiographic
screening for RHD is appropriate, feas-
ible and cost-effective will vary
between settings, and remains a topic
of vigorous debate.6,23-25 A cost-effec-
tiveness analysis of our data is under-
way and will contribute to our ultimate
recommendations about the future of
echocardiographic screening in Indig-
enous Australian children who are at
high risk of RHD.
A limitation of this study is that aus-
cultation was carried out by several dif-
ferent doctors and nurses, potentially
leading to high interobserver variation.
Similarly, the screening environment
varied between communities, and the
conditions under which auscultation
was performed (eg, in a quiet room)
were not the same for all participants.
However, we believe that these limita-
tions reflect the day-to-day reality of
health care service provision in the par-
ticipating communities, allowing valid
extrapolation of our results to the cur-
rent school screening procedure in the
NT and many other settings.
We conclude that cardiac ausculta-
tion is not an effective method of RHD
screening, regardless of the expertise of
the auscultator. The risk of missing
more than 50% of children with RHD,
and the risk of overburdening cardi-
ology services with false positives, pre-
clude recommendation of one-stage or
two-stage auscultation as a rational
approach to RHD screening. We
recommend that cardiac auscultation
no longer be used to screen for RHD in
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